News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,832 Results
Type
Article (86713)
Company Profile (703)
Press Release (763414)
Multimedia
Podcasts (138)
Webinars (17)
Section
Business (232764)
Career Advice (4130)
Deals (39742)
Drug Delivery (129)
Drug Development (91055)
Employer Resources (198)
FDA (18154)
Job Trends (17353)
News (396683)
Policy (39791)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (101)
Alliances (56927)
ALS (112)
Alzheimer's disease (1535)
Antibody-drug conjugate (ADC) (184)
Approvals (18102)
Artificial intelligence (365)
Autoimmune disease (34)
Automation (18)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (374)
Cancer (2888)
Cardiovascular disease (232)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (33)
Cell therapy (548)
Cervical cancer (23)
Clinical research (73987)
Collaboration (1033)
Company closure (3)
Compensation (649)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (315)
Cystic fibrosis (116)
Data (2859)
Decentralized trials (2)
Denatured (48)
Depression (65)
Diabetes (328)
Diagnostics (6958)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (165)
Drug pricing (147)
Drug shortages (35)
Duchenne muscular dystrophy (122)
Earnings (97408)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131215)
Executive appointments (875)
FDA (19744)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (933)
Gene editing (141)
Generative AI (36)
Gene therapy (414)
GLP-1 (893)
Government (5222)
Grass and pollen (6)
Guidances (179)
Healthcare (20911)
Huntington's disease (29)
IgA nephropathy (39)
Immunology and inflammation (171)
Immuno-oncology (7)
Indications (36)
Infectious disease (3069)
Inflammatory bowel disease (162)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (114)
Interviews (813)
IPO (17882)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (53)
Layoffs (582)
Leadership (25)
Legal (10126)
Liver cancer (83)
Lung cancer (409)
Lymphoma (199)
Machine learning (9)
Management (65)
Manufacturing (408)
MASH (92)
Medical device (14690)
Medtech (14695)
Mergers & acquisitions (22520)
Metabolic disorders (874)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (134)
Neuropsychiatric disorders (37)
Neuroscience (2239)
NextGen: Class of 2025 (7687)
Non-profit (5087)
Now hiring (46)
Obesity (461)
Opinion (285)
Ovarian cancer (96)
Pain (115)
Pancreatic cancer (109)
Parkinson's disease (188)
Partnered (25)
Patents (293)
Patient recruitment (141)
Peanut (53)
People (65570)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22850)
Phase II (32124)
Phase III (24189)
Pipeline (1599)
Policy (214)
Postmarket research (3552)
Preclinical (10316)
Press Release (72)
Prostate cancer (138)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (490)
Real estate (7397)
Recruiting (75)
Regulatory (26997)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (91)
Series A (159)
Series B (105)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (36)
Startups (4298)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (63)
The Weekly (88)
Vaccines (874)
Venture capitalists (51)
Weight loss (315)
Women's health (46)
Worklife (20)
Date
Today (72)
Last 7 days (541)
Last 30 days (2558)
Last 365 days (34777)
2025 (16371)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (66)
Alaska (7)
Arizona (278)
Arkansas (14)
Asia (50406)
Australia (8862)
California (7433)
Canada (2296)
China (676)
Colorado (319)
Connecticut (334)
Delaware (190)
Europe (115649)
Florida (1098)
Georgia (251)
Hawaii (1)
Idaho (65)
Illinois (708)
India (32)
Indiana (369)
Iowa (16)
Japan (218)
Kansas (115)
Kentucky (30)
Louisiana (17)
Maine (73)
Maryland (1064)
Massachusetts (5668)
Michigan (267)
Minnesota (463)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (72)
New Jersey (2072)
New Mexico (31)
New York (2084)
North Carolina (1208)
North Dakota (10)
Northern California (3209)
Ohio (242)
Oklahoma (16)
Oregon (48)
Pennsylvania (1590)
Puerto Rico (17)
Rhode Island (39)
South America (1653)
South Carolina (34)
South Dakota (1)
Southern California (2738)
Tennessee (121)
Texas (1116)
United States (28067)
Utah (220)
Virginia (198)
Washington D.C. (79)
Washington State (659)
West Virginia (4)
Wisconsin (81)
There are 850,832 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Duchenne muscular dystrophy
Second Patient Dies After Receiving Sarepta’s DMD Gene Therapy Elevidys
Sarepta’s shares crashed 41% in pre-market trading Monday morning to $21.01 after the biotech reported a second death from acute liver failure, a known side effect of adeno-associated virus-based gene therapies.
June 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241
June 16, 2025
·
2 min read
Press Releases
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure
June 16, 2025
·
2 min read
Press Releases
ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope
June 16, 2025
·
4 min read
Press Releases
Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease
June 16, 2025
·
6 min read
Press Releases
Notice To Extraordinary General Meeting In Alzecure Pharma AB
June 16, 2025
·
7 min read
Press Releases
HekaBio, Japan-based Biopharma and MedTech Platform, Enters Strategic Partnership with Alfresa Holdings Corporation
June 16, 2025
·
2 min read
Press Releases
Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson’s Disease
June 16, 2025
·
5 min read
Press Releases
Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease
June 16, 2025
·
5 min read
Press Releases
Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025
June 16, 2025
·
7 min read
1 of 85,084
Next
